Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19) Situation Summary Background CDC is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in Wuhan City, Hubei Province, China and which has now been detected in 37 locations internationally, including cases in the United States. The virus has been named “SARS-CoV2” and the disease it causes has been named “coronavirus disease 2019” (abbreviated “COVID-19”). On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization declared the outbreak a “public health emergency of international concernexternal icon” (PHEIC). On January 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency (PHE) for the United States to aid the nation’s healthcare community in responding to COVID-19.
Source and Spread of the Virus Coronaviruses are a large family of viruses that are common in many different species of animals, including camels, cattle, cats, and bats. Rarely, animal coronaviruses can infect people and then spread between people such as with MERS-CoV, SARS-CoV, and now with this new virus (named SARSCoV-2). The SARS-CoV-2 virus is a betacoronavirus, like MERS-CoV and SARS-CoV. All three of these viruses have their origins in bats. The sequences from U.S. patients are similar to the one that China initially posted, suggesting a likely single, recent emergence of this virus from an animal reservoir. Early on, many of the patients in the COVID-19 outbreak in Wuhan, China had some link to a large seafood and live animal market, suggesting animal -to-person spread. Later, a growing number of patients reportedly did not have exposure to animal markets, indicating person-to-person spread. Person-to-person spread has been reported outside China, including in the United States and other locations. Chinese officials report that sustained person-to-person spread in the community is occurring in China. In addition, other destinations have apparent community spread, meaning some people have been infected who are not sure how or where they became infected. Learn what is known about the spread of newly emerged coronaviruses.
Situation in U.S. Imported cases of COVID-19 in travelers have been detected in the U.S. Person-to-person spread of COVID-19 also has been seen among close contacts of returned travelers from Wuhan, but at this time, this virus is NOT currently spreading in the community in the United States.
Illness Severity Both MERS-CoV and SARS-CoV have been known to cause severe illness in people. The complete clinical picture with regard to COVID-19 is not fully understood. Reported illnesses have ranged from mild to severe, including illness resulting in death. Learn more about the symptoms associated with COVID-19. There are ongoing investigations to learn more. This is a rapidly evolving situation and information will be updated as it becomes available.
Risk Assessment Outbreaks of novel virus infections among people are always of public health concern. The risk from these outbreaks depends on characteristics of the virus, including how well it spreads between people, the severity of resulting illness, and the medical or other measures available to control the impact of the virus (for example, vaccine or treatment medications). The fact that this disease has caused illness, including illness resulting in death, and sustained person-to-person spread is concerning. These factors meet two of the criteria of a pandemic. As community spread is detected in more and more countries, the world moves closer toward meeting the third criteria, worldwide spread of the new virus. The potential public health threat posed by COVID-19 is high, both globally and to the United States. But individual risk is dependent on exposure. For the general American public, who are unlikely to be exposed to this virus at this time, the immediate health risk from COVID-19 is considered low. Under current circumstances, certain people will have an increased risk of infection, for example healthcare workers caring for patients with COVID19 and other close contacts of persons with COVID-19. CDC has developed guidance to help in the risk assessment and management of people with potential exposures to COVID-19. However, it’s important to note that current global circumstances suggest it is likely that this virus will cause a pandemic. In that case, the risk assessment would be different. 
What May Happen More cases are likely to be identified in the coming days, including more cases in the United States. It’s also likely that person-to-person spread will continue to occur, including in the United States. Widespread transmission of COVID-19 in the United States would translate into large numbers of people needing medical care at the same time. Schools, childcare centers, workplaces, and other places for mass gatherings may experience more absenteeism. Public health and healthcare systems may become overloaded, with elevated rates of hospitalizations and deaths. Other critical infrastructure, such as law enforcement, emergency medical services, and transportation industry may also be affected. Health care providers and hospitals may be overwhelmed. At this time, there is no vaccine to protect against COVID-19 and no medications approved to treat it. Nonpharmaceutical interventions would be the most important response strategy.
CDC Response Global efforts at this time are focused concurrently on containing spread of this virus and mitigating the impact of this virus. The federal government is working closely with state, local, tribal, and territorial partners, as well as public health partners, to respond to this public health threat. The public health response is multi-layered, with the goal of detecting and minimizing introductions of this virus in the United States so as to reduce the spread and the impact of this virus. CDC is operationalizing all of its pandemic preparedness and response plans, working on multiple fronts to meet these goals, including specific measures to prepare communities to respond local transmission of the virus that causes COVID-19. There is an abundance of pandemic guidance developed in anticipation of an influenza pandemic that is being repurposed and adapted for a COVID-19 pandemic.
Highlights of CDC’s Response CDC established a COVID-19 Incident Management System on January 7, 2020. On January 21, CDC activated its Emergency Operations Center to better provide ongoing support to the COVID-19 response. The U.S. government has taken unprecedented steps with respect to travel in response to the growing public health threat posed by this new coronavirus: Effective February 2, at 5pm, the U.S. government suspended entry of foreign nationals who have been in China within the past 14 days. U.S. citizens, residents, and their immediate family members who have been in Hubei province and other parts of mainland China are allowed to enter the United States, but they are subject to health monitoring and possible quarantine for up to 14 days. CDC has issued the following travel guidance related to COVID-19: China — Level 3, Avoid Nonessential Travel — updated February 22; South Korea — Level 3, Avoid Nonessential Travel — updated February 24; Japan — Level 2, Practice Enhanced Precautions — updated February 22; Iran — Level 2, Practice Enhanced Precautions — issued February 23; Italy — Level 2, Practice Enhanced Precautions — issued February 23; Hong Kong — Level 1, Practice Usual Precautions — issued February 19.
CDC also recommends that all travelers reconsider cruise ship voyages into or within Asia at this time. CDC is issuing clinical guidance, including: An interim Health Alert Network (HAN) Update to inform state and local health departments and healthcare professionals about this outbreak on February 1. On January 30, CDC published guidance for healthcare professionals on the clinical care of COVID-19 patients. On February 3, CDC posted guidance for assessing the potential risk for various exposures to COVID-19 and managing those people appropriately.
CDC has worked with the Department of State, supporting the safe return of Americans who have been stranded as a result of the ongoing outbreaks of COVID -19 and related travel restrictions. CDC has worked to assess the health of passengers as they return to the United States and provided continued daily monitoring of people who are quarantined. CDC laboratories have supported the COVID-19 response, including: CDC has developed a real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) test that can diagnose COVID-19 in respiratory samples from clinical specimens. On January 24, CDC publicly posted the assay protocol for this test.  CDC has been uploading the entire genome of the viruses from reported cases in the United States to GenBank as sequencing was completed. CDC has grown the COVID-19 virus in cell culture, which is necessary for further studies, including for additional genetic characterization. The cellgrown virus was sent to NIH’s BEI Resources Repositoryexternal icon for use by the broad scientific community.
CDC Recommends
While the immediate risk of this new virus to the American public is believed to be low at this time, everyone can do their part to help us respond to this emerging public health threat: It’s currently flu and respiratory disease season and CDC recommends getting a flu vaccine, taking everyday preventive actions to help stop the spread of germs, and taking flu antivirals if prescribed. If you are a healthcare provider, be on the look-out for people who recently traveled from China and have fever and respiratory symptoms. If you are a healthcare provider caring for a COVID-19 patient or a public health responder, please take care of yourself and follow recommended infection control procedures. If you have been in China or have been exposed to someone sick with COVID-19 in the last 14 days, you will face some limitations on your movement and activity. Please follow instructions during this time. Your cooperation is integral to the ongoing public health response to try to slow spread of this virus. If you develop COVID-19 symptoms, contact your healthcare provider, and tell them about your symptoms and your travel or exposure to a COVID-19 patient. For people who are ill with COVID-19, please follow CDC guidance on how to reduce the risk of spreading your illness to others.
World experts and funders set priorities for COVID-19 research Leading health experts from around the world have been meeting at the World Health Organization’s Geneva headquarters to assess the current level of knowledge about the new COVID-19 disease, identify gaps and work together to accelerate and fund priority research needed to help stop this outbreak and prepare for any future outbreaks. The 2-day forum was convened in line with the WHO R&D Blueprint – a strategy for developing drugs and vaccines before epidemics, and accelerating research and development while they are occurring. “This outbreak is a test of solidarity -- political, financial and scientific. We need to come together to fight a common enemy that does not respect borders, ensure that we have the resources necessary to bring this outbreak to an end and bring our best science to the forefront to find shared answers to shared problems. Research is an integral part of the outbreak response,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “I appreciate the positive response of the research community to join us at short notice and come up with concrete plans and commitment to work together.”
The meeting, hosted in collaboration with GloPID -R (the Global Research Collaboration for Infectious Disease Preparedness) brought together major research funders and over 300 scientists and researchers from a large variety of disciplines. They discussed all aspects of the outbreak and ways to control it including:
the natural history of the virus, its transmission and diagnosis; animal and environmental research on the origin of the virus, including management measures at the human-animal interface; epidemiological studies; clinical characterization and management of disease caused by the virus; infection prevention and control, including best ways to protect health care workers; research and development for candidate therapeutics and vaccines; ethical considerations for research; and integration of social sciences into the outbreak response. “This meeting allowed us to identify the urgent priorities for research. As a group of funders we will continue to mobilize, coordinate and align our funding to enable the research needed to tackle this crisis and stop the outbreak, in partnership with WHO,” said Professor Yazdan Yazdanpanah, chair of GloPID-R. “Equitable access – making sure we share data and reach those most in need, in particular those in lower and middle-income countries, is fundamental to this work which must be guided by ethical considerations at all times.”
During the meeting, the more than 300 scientists and researchers participating both in person and virtually agreed on a set of global research priorities. They also outlined mechanisms for continuing scientific interactions and collaborations beyond the meeting which will be coordinated and facilitated by WHO. They worked with research funders to determine how necessary resources can be mobilized so that critical research can start immediately. The deliberations will form the basis of a research and innovation roadmap charting all the research needed and this will be used by researchers and funders to accelerate the research response.
Online training as a weapon to fight the new coronavirus More than 25 000 people across the globe have accessed real-time knowledge from WHO experts on how to detect, prevent, respond to and control the new coronavirus in the 10 days since the launch of an open online training. The learning team of the WHO Health Emergencies Programme worked with technical experts to quickly develop and publish the online course on 26 January – 4 days before the 2019-nCoV outbreak was declared a public health emergency of international concern. Approximately 3000 new users have registered for the training every day since its launch, demonstrating the high level of interest in the virus among health professionals and the general public. In addition, more than 200 000 people have viewed the introductory video to the course on YouTube. The high engagement levels emerged as the international community launched a US$675 million preparedness and response plan to fight further spread of the new coronavirus and protect states with weaker health systems. The free learning resource is available to anyone interested in novel coronavirus on WHO’s open learning platform for emergencies, OpenWHO.org. The platform was established 3 years ago with emergencies such as nCoV in mind, in which WHO would need to reach millions of people across the globe with real-time, accessible learning materials. The online training – entitled “Emerging respiratory viruses, including nCoV: methods for detection, prevention, response and control” – is currently being produced in all official UN languages and Portuguese.
“Our job is to work with technical health experts to package knowledge using adult learning principles, quickly so that it is most useful to health workers and our staff,” said Heini Utunen, who manages OpenWHO for the WHO Health Emergencies Programme (WHE). “Our online platform – OpenWHO – is already accessed by users from every country on earth, providing more than 60 courses in 21 languages. Delivering trainings in the local language of responders is really important, especially in an emergency”. WHE has been investing in learning and training to strengthen preparedness and real-time response to health emergencies. The programme developed its first-ever learning strategy in 2018 and has a small dedicated Learning and Capacity Development Unit that allows WHE to develop trainings quickly and get know-how to those who most need it at the front line. For the latest information on the new coronavirus, visit the 2019-nCoV page.
WHO Director-General's opening remarks at the mission briefing on COVID-19 - 26 February 2020 Excellencies, dear colleagues and friends, First of all, good morning and welcome to our weekly mission briefing on COVID-19. I’m glad that we’re maintaining these regular briefings. A lot has changed since we briefed you last Wednesday, which illustrates the rapidly evolving nature of this epidemic. As of 6am Geneva time this morning, China has reported 78,190 cases to WHO, including 2718 deaths. Yesterday, only 10 new cases were reported in China outside of Hubei province. But this is no time for complacency. This is a time for continued vigilance. On Monday, the WHO-China joint mission concluded its visit and delivered its report. As you also know, the team has traveled to several different provinces, including Wuhan, the epicenter of the outbreak. The team has made a range of findings about the transmissibility of the virus, the severity of disease and the impact of the measures taken. They found that the epidemic peaked and plateaued between the 23rd of January and the 2nd of February, and has been declining steadily since then. They have found that there has been no significant change in the genetic makeup of the virus.
The team also estimate that the measures taken in China have averted a significant number of cases. The report contains a wealth of other information, highlights questions for which we still don’t have answers, and includes 22 recommendations. But the key message that should give all countries hope, courage and confidence is that this virus can be contained. Indeed, there are many countries that have done exactly that. 14 countries that have had cases have not reported a case for more than a week, and even more importantly, 9 countries have not reported a case for more than two weeks: Belgium, Cambodia, Finland, India, Nepal, Philippines, the Russian Federation, Sri Lanka and Sweden. But that doesn’t mean that cases may not come back to these countries. But the cases that made it before have been contained. Outside China, there are now 2,790 cases in 37 countries, and 44 deaths. Yesterday, the number of new cases reported outside China exceeded the number of new cases in China for the first time. The sudden increases of cases in Italy, the Islamic Republic of Iran and the Republic of Korea are deeply concerning. There are now cases linked to Iran in Bahrain, Iraq, Kuwait and Oman. There are now cases linked to Italy in Algeria, Austria, Croatia, Germany, Spain and Switzerland. Yesterday a joint team between WHO and the European Centre for Disease Prevention and Control arrived in Rome to review the public health measures that have been put in place and provide technical support. A WHO team will travel to Iran this weekend to provide support. The increase in cases outside China has prompted some media and politicians to push for a pandemic to be declared. We should not be too eager to declare a pandemic without a careful and clear-minded analysis of the facts. WHO has already declared a public health emergency of international concern – our highest level of alarm. Using the word pandemic carelessly has no tangible benefit, but it does have significant risk in terms of amplifying unnecessary and unjustified fear and stigma, and paralyzing systems.
It may also signal that we can no longer contain the virus, which is not true. We are in a fight that can be won if we do the right things. Of course, we will not hesitate to use the word pandemic if it is an accurate description of the situation. We are monitoring the evolution of the epidemic around the clock, 24/7 and are engaging experts internally and externally on this issue. For the moment, we are not witnessing sustained and intensive community transmission of this virus, and we are not witnessing large-scale severe disease or death. China has fewer than 80,000 cases in a population of 1.4 billion people. In the rest of the world, there are 2,790 cases, in a population of 6.3 billion. Do not mistake me: I am not downplaying the seriousness of the situation, or the potential for this to become a pandemic, because it has that potential. Every scenario is still on the table. On the contrary, we are saying that this virus has pandemic potential and WHO is providing the tools for every country to prepare accordingly. The primary objective of all countries with cases must be to contain the virus. As I told you, I read the list of 9 countries who have not reported cases for two weeks. We should do the same: try to contain. At the same time, all countries, whether they have cases or not, must prepare for a potential pandemic. Every country needs to be ready to detect cases early, to isolate patients, trace contacts, provide quality clinical care, prevent hospital outbreaks, and prevent community transmission. There are three priorities:
First, all countries must prioritize protecting health workers. Second, we must engage communities to protect people who are most at risk of severe disease, particularly the elderly and people with underlying health conditions. And third, we must protect countries that are the most vulnerable, by doing our utmost to contain epidemics in countries with the capacity to do it. To support countries, WHO has published operational planning guidelines to support country preparedness and response. These guidelines provide a stepby-step guide, with concrete actions according to eight areas – or pillars: Country-level coordination, planning and monitoring; Risk communication and community engagement; Surveillance, rapid response teams and case investigation; Points of entry; National laboratories; Infection prevention and control; Case management; And operational support and logistics. The guidelines also include key performance indicators, and the estimated resources needed to prepare for and respond to a cluster of up to 100 cases. To supplement these operational guidelines, we have also published technical guidance in many of these areas, which are available on our website. On Saturday I briefed a meeting of health ministers from African Union countries. There are now 41 countries with laboratory capacity for testing for COVID-19, using lab kits sent by WHO. We are working on sending supplies to the other AU countries. There was only one country that was able to test – now 41, but we should make sure that all countries have that capacity.
I’m also pleased to announce that we have appointed six special envoys on COVID-19, to provide strategic advice and high-level political advocacy and engagement in different parts of the world: Professor Maha El Rabbat, former Minister of Health of Egypt; Dr David Nabarro, former special adviser to the United Nations Secretary-General on the Sustainable Development Goals; Dr John Nkengasong, Director of the African Centres for Disease Control and Prevention; Dr Mirta Roses, former Director of the WHO Region of the Americas, PAHO; Dr Shin Young-soo, former Regional Director of the WHO Region of the Western Pacific; And Professor Samba Sow, Director-General of the Center for Vaccine Development in Mali. We are also continuing to strengthen our coordination with the UN Crisis Management Team. Yesterday the Strategic Advisory Group on Infectious Hazards met, and this afternoon we will have our weekly call with the informal group of experts we have put together to advise us. I would like to thank all countries and partners that have contributed to the Strategic Preparedness and Response Plan and the Contingency Fund for Emergencies: Canada, the Czech Republic, Denmark, the European Union, France, Germany, Ireland, Japan, Kuwait, the Netherlands, Norway, Slovakia, Sweden the United Kingdom, the Bill and Melinda Gates Foundation, Vital Strategies and Resolve to Save Lives.
We also recognize the generous pledge of support from the United States Government to assist China and other affected countries to combat and contain COVID-19. We are now working to distribute these funds as quickly as possible to the priority countries we have identified. Most of the contributions made so far are pledges, so rather than waiting for funds to be received, we are using our own internal lending mechanism to accelerate the distribution of money. We look forward to receiving monies pledged as soon as possible, because we have limited funding. One of the biggest challenges we face is that too many affected countries are still not sharing data with WHO. WHO cannot provide appropriate public health guidance without disaggregated data and detailed line lists. We’re communicating with ministers directly, there is some improvement, and we urge all countries to share this data with WHO immediately. === Excellencies, dear colleagues and friends, We are not just fighting to contain a virus and save lives. We are also in a fight to contain the social and economic damage a global pandemic could do. We are working with the World Bank and the IMF to estimate the potential economic impact of the epidemic and develop a strategy and policy options for mitigation. We’re in constant contact with the heads of the two organizations. Once again, this is a time for global solidarity – political solidarity, technical solidarity and financial solidarity. That is the only way to prevent infections and save lives. Thank you again for joining us.
Կորոնավիրուս Նոր կորոնավիրուսային վարակի դեմ պայքարի միջոցառումները՝ սահմանային հսկողությունից մինչ լաբորատոր հետազոտություններ շարունակվում են. իրականացվել է 95 հետազոտություն՝ բացասական արդյունքով Նոր կորոնավիրուսային վարակի (CՕVID-19) դեմ պայքարի համալիր միջոցառումները՝ սահմանային հսկողությունից մինչ լաբորատոր հետազոտություններ շարունակվում են: Իրականացվել է 95 հետազոտություն՝ բացասական արդյունքով: Այս մասին հատնում են ՀՀ առողջապահության նախարարությունից: Հանրապետության բժշկական կազմակերպություններում նոր կորոնավիրուսային վարակի (CՕVID-19) դիմակայումն ապահովելու համար իրականացվում են բուժանձնակազմի պատրաստվածությանն ուղղված միջոցառումներ: Մշտական կապ է հաստատվել Առողջապահության համաշխարհային կազմակերպության և տարածաշրջանի գործընկերների հետ՝ վարակի դեմ պայքարի գործում կարողությունների քննարկման նպատակով: Առողջապահության համաշխարհային կազմակերպության տվյալներով` փետրվարի 26-ի դրությամբ գլոբալ մակարդակով արձանագրվել է նոր կորոնավիրոսային վարակի (COVID-19) 81109 հաստատված դեպք: Չինաստանում արձանագրվել է 78191 դեպք, որից 2718-ը մահվան ելքով: Չինաստանից դուրս 2918 դեպք է արձանագրվել 37 երկրում, որից 43-ը մահվան ելքով: Չինաստանի Առողջապահության պետական հանձնաժողովի ամենօրյա զեկույցի համաձայն` փետրվարի 27-ի, ժամը 14:00 դրությամբ Չինաստանում կորոնավիրուսային հիվանդությամբ (COVID-19) հաստատված դեպքերի թիվը կազմել է 78631, հաստատված դեպքերից առողջացածների թիվը՝ 32,654: Գրանցվել է 2747 մահ: Ըստ նույն աղբյուրի` փետրվարի 27-ի, ժամը 09:00-ի դրությամբ աշխարհում արձանագրվել է 82206 հաստատված դեպք: Չինաստանից դուրս աշխարհի 46 երկրում գրանցվել է 3575 դեպք
Կորոնավիրուս «Աշխարհը պետք է պատրաստ լինի կորոնավիրուսի համավարակի». Առողջապահության համաշխարհային կազմակերպություն
Առողջապահության համաշխարհային կազմակերպությունը (ԱՀԿ) հայտնել է, որ թեև դեռևս վաղ է կորոնավիրուսի համավարակի (պանդեմիայի) մասին հայտարարել, սակայն երկրները պետք է պատրաստ լինեն ցանկացած զարգացման, հայտնում է BBC-կայքը՝ մանրամասնելով, որ համավարակը բնորոշվում է աշխարհի բազմաթիվ երկրներում վարակիչ հիվանդությունների արագ տարածմամբ։ Covid-19 տեսակի կորոնավիրուսի հարուցիչով պայմանավորված
հիվանդությունը շարունակվում է արագորեն տարածվել մի շարք երկրներում: ԱՀԿ ղեկավարի խոսքով` առավել անհանգստացնող են վերջին օրերին Հարավային Կորեայում, Իտալիայում, Իրանում գրանցված դեպքերը: Այնուամենայնիվ ամենաշատ դեպքերը գրանցվել են համաճարակի օջախ դարձած Չինաստանում, որտեղ գրանցվել է վարակի 77 000 դեպք, որից` 2600-ը մահվան ելքով: Չինաստանի սահմաններից դուրս 30 երկրում հաստատվել է վարակման 1200 դեպք, որից 20-ը` մահվան ելքով: Covid-19 կորոնավիրուսից մահացության տոկոսը տատանվում է 1-2-ի միջև` չնայած ԱՀԿ-ն
Կորոնավիրուս զգուշացնում է, որ այս տվյալների մասին ամենայն վստահությամբ չի կարելի խոսել: Երկուշաբթի օրը վարակման առաջին դեպքեր են գրանցվել նաև Աֆղանստանում, Քուվեյթում, Օմանում և Բահրեյնում, որտեղ վարակակիրները ժամանել են Իրանից: Կորոնավիրուսի տնտեսական ազդեցության հետևանքով համաշխարհային արժեթղթային շուկայում կտրուկ անկումներ են եղել: Չինաստանն իր հերթին հայտնել է, որ կորոնավիրուսի դեմ պայքարը շարունակելու նպատակով պատրաստվում է հետաձգել Ժողովրդական ներկայացուցիչների համաչինական ժողովը:
Americare Hospice, Inc Americare Hospice, Inc is a hospice care center situated at Los Angeles, California. This palliative care is medicare certified, hence if you are covered by medicare, medicare will pay the hospice for your care.
4430 Santa Monica Blvd, Los Angeles, CA 90029
818-641-5957
Կորոնավիրուս Կորոնավիրուսային թոքաբորբը, որպես կանոն, բարդություններ չի առաջացնում. չինացի ակադեմիկոս
Covid-19 նոր կորոնավիրուսի հարուցած թոքաբորբը, որպես կանոն, բարդություններ չի առաջացնում ապաքինումից հետո: Այդ մասին լրագրողներին հայտարարել է ՉԺՀ-ի Գիտությունների ակադեմիայի անդամ Վան Ֆուշենը Պեկինում կայացած մամուլի ասուլիսում։ Նրա խոսքով՝ հիվանդության կլինիկական ախտանիշներն անհետանում են մեկ շաբաթվա ընթացքում, իսկ հիվանդության թեթեւ եւ միջին ձեւով հիվանդների բաժինը գերազանցում է 80 տոկոսը: Գիտնականը նշել է, որ ճիշտ ռեժիմի դեպքում. լավ հանգիստ, սնունդ, դեղորայքի ժամանակին ընդունում, մարդու իմունիտետն ունակ է ինքը հաղթելու վարակը: «Հիվանդությունը մեծավ մասամբ անցնում է առանց հետեւանքների, ուստի խուճապի համար հիմքեր չկան»,- ընդգծել է ակադեմիկոսը: Ավելի վաղ ՉԺՀ-ի Առողջապահության գործերի կոմիտեն արդեն հայտնել է, որ կորոնավիրուսով հիվանդների մեծ մասի համար կանխատեսումը բարենպաստ է: Երիտասարդները եւ երեխաները հիվանդությունը թեթեւ են տանում: Covid-19-ն առավել մեծ վտանգ է ներկայացնում տարեց մարդկանց համար, հաղորդել է «Ինտերֆաքս»-ը: